| Proposed Ticker: CTIC | ||
| Exchange: NASDAQ-National Market | Seattle, Washington | |
| Industry: Manufacturing |
| All share information is proposed | ||||
| Type of Shares: | Common Shares | Filing Date: | 4/29/96 | |
| U.S. Shares Filed: | 3,500,000 | Filing Price: | $11.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $38,500,000 | |
| Primary Shares: | 3,500,000 | Expenses: | $700,000 | |
| Secondary Shares: | 0 | Shs Out After: | 10,409,059 | |
| Manager | Tier | Phone |
| CS First Boston | Lead Manager | (212) 909-3312 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| Revenue: | Assets: | ||||
| Net Income: | Liabilities: | ||||
| EPS: | Equity: | ||||
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company develops small molecule drugs that modulate the production of cell membrance lipids called phosphatidic acids for the treatment of cancer and inflammatory and immune diseases. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for clinical trials and other research and development, general corporate purposes and working capital. |
©1996 IPO Data Systems, Inc. - All rights reserved.